Critically Ill COVID-19 Patients Show Reduced Point of Care-Measured Butyrylcholinesterase Activity—A Prospective, Monocentric Observational Study

A biomarker for risk stratification and disease severity assessment in SARS-CoV-2 infections has not yet been established. Point of care testing (POCT) of butyrylcholinesterase (BChE) enables early detection of systemic inflammatory responses and correlates with disease severity in sepsis and burns....

Descripción completa

Detalles Bibliográficos
Autores principales: Espeter, Florian, Künne, David, Garczarek, Lena, Kuhlmann, Henning, Skarabis, Annabell, Zivkovic, Aleksandar R., Brenner, Thorsten, Schmidt, Karsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498245/
https://www.ncbi.nlm.nih.gov/pubmed/36140551
http://dx.doi.org/10.3390/diagnostics12092150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498245/
https://www.ncbi.nlm.nih.gov/pubmed/36140551
http://dx.doi.org/10.3390/diagnostics12092150

Ejemplares similares